BlackRock Smaller Companies Trust is a newly minted ‘dividend hero’

BlackRock

BlackRock Smaller Companies Trust plc (LON:BRSC) has announced its fund analysis by Kepler:

In our view, the continuity and consistency of BRSC’s investment process (see Portfolio) has been a significant contributor to the trust’s ability to deliver strong performance for investors over the long term, having generated an annualised total return of 9.1% over the past ten years. Over the past five years, BRSC has generated a NAV total return of 5.3%, outperforming the benchmark’s return of 1%, but underperforming the peer group average over the same period.

As we discuss in the Performance section, BlackRock Smaller Companies Trust’s recent underperformance has followed a prolonged period of outperformance and comes at a time of elevated volatility. In our analysis, BRSC’s relatively high performance and consistency scores show that investors have been generally rewarded for taking on the additional risk of the strategy. Roland’s focus on identifying high-quality businesses, together with his patience to remain invested over the long term, has translated into positive alpha relative to the benchmark and peers.

BRSC has a current yield of 3.1%, which is the second-highest in the sector. BRSC has significant revenue reserves, which the board can use in support of the dividend, thus providing a degree of reassurance. At the time of writing, BRSC trades at a 13.3% discount to NAV, which is slightly narrower than the AIC UK Smaller Companies sector average of 14.5%, according to JPMorgan Cazenove, as at 23/05/2023. As the second-largest trust in the AIC UK Smaller Companies sector, BRSC benefits from good liquidity in its shares. In light of this, the rigorous and consistent investment process and strong long-term track record, not to mention the trust’s low charges, we believe that the current discount level may present an attractive entry opportunity for longer-term investors.

To learn more about the BlackRock Smaller Companies Trust plc please follow this link: blackrock.com/uk/brsc

Share on:
Find more news, interviews, share price & company profile here for:

      Global Opportunities Trust reports 11.9% one year share price return to 31 August

      Global Opportunities Trust has released its August 2025 factsheet, reporting a 12-month NAV increase of 8.8% and a share price gain of 11.8%.

      Dekel Agri-Vision reports 24.5% revenue growth and break-even net profit in H1 2025

      Dekel Agri-Vision posted a stronger performance for the six months ended 30 June 2025, with Group revenue up 24.5% to €23.9m and EBITDA rising 10.7% to €3.1m.

      Aptamer Group to present at ShareSoc Growth Company seminar in Leeds

      Aptamer will present at the ShareSoc Growth Company Seminar on Wednesday, 8 October 2025, at the Leonardo Hotel, Leeds. CEO Dr Arron Tolley and CFO Andrew Rapson will update investors on the Company’s progress, with a recording of the presentation to be published on the Aptamer website after the event.

      Quadrise signs addendum with Valkor to re-phase payments and MMU deliveries

      Quadrise has agreed an addendum to its Site License and Supply Agreement with Valkor Technologies in Utah. The revised terms re-phase the US$1.0 million licence fee through to June 2026 and adjust delivery schedules for Multifuel Manufacturing Units.

      Ampeak Energy reports interim results and financial close of first battery project

      Ampeak Energy has published its unaudited interim results for the six months ended 30 June 2025. The Group focused on achieving financial close of the 240 MWh AW1 battery project at Uskmouth, which was completed in August 2025.

      Nuformix to present NXP002 data at ERS Congress 2025

      Nuformix will attend the European Respiratory Society Congress in Amsterdam from 28 September 2025, where it will present new findings from its lead programme, NXP002, an inhaled treatment for idiopathic pulmonary fibrosis.

        Search

        Search